SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Francesco Massari, Chiara Ciccarese, Davide Bimbatti, Emanuela Fantinel, Alessandra Modena, Michele Simbolo, Matteo Brunelli, Walter Artibani, Guido Martignoni, Aldo Scarpa, Giampaolo Tortora, Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma, Anti-Cancer Drugs, 2015, 26, 4, 469

    CrossRef

  2. 2
    Roberto Iacovelli, Francesco Massari, Laurence Albiges, Yohann Loriot, Christophe Massard, Karim Fizazi, Bernard Escudier, Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell Carcinoma, European Urology, 2014,

    CrossRef

  3. 3
    Roberto Iacovelli, Daniele Alesini, Antonella Palazzo, Patrizia Trenta, Matteo Santoni, Laura De Marchis, Stefano Cascinu, Giuseppe Naso, Enrico Cortesi, Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials, Cancer Treatment Reviews, 2014, 40, 2, 271

    CrossRef

  4. 4
    Mathilde Guerin, Naji Salem, Jochen Walz, Slimane Dermeche, Gwenaelle Gravis, Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up, World Journal of Surgical Oncology, 2013, 11, 1, 243

    CrossRef

  5. 5
    Bernard Escudier, Laurence Albiges, Guru Sonpavde, Optimal Management of Metastatic Renal Cell Carcinoma: Current Status, Drugs, 2013, 73, 5, 427

    CrossRef

  6. 6
    Steffen Weikert, Viktor Grünwald, Reply from Authors re: Camillo Porta, Chiara Paglino. Experience Gathered from Retrospective Series on Renal Cell Carcinoma Is Useful, But Now It Is Time for a Global Claim for Academically Driven Prospective Studies. Eur Urol 2013;64:71–2, European Urology, 2013, 64, 1, 72

    CrossRef

  7. 7
    Peg Esper, Concepts in Advanced Renal Carcinoma, Seminars in Oncology Nursing, 2012, 28, 3, 170

    CrossRef

  8. 8
    Giuseppe Procopio, Roberto Sabbatini, Camillo Porta, Elena Verzoni, Enzo Galligioni, Cinzia Ortega, Optimizing further treatment choices in short- and long-term responders to first-line therapy for patients with advanced renal cell carcinoma, Expert Review of Anticancer Therapy, 2012, 12, 8, 1089

    CrossRef